Strategy
MSTR
Deere
DE
Steel Dynamics
STLD
4
Rumble
RUM
5
Goldman Sachs
GS
US Stock MarketDetailed Quotes
CPRX Catalyst Pharmaceuticals
- 23.270
- +0.010+0.04%
Close Feb 14 16:00 ET
- 23.070
- -0.200-0.86%
Post 20:01 ET
2.78BMarket Cap19.72P/E (TTM)
23.350High22.845Low954.59KVolume23.260Open23.260Pre Close22.12MTurnover0.91%Turnover Ratio36.94P/E (Static)119.27MShares24.64052wk High4.20P/B2.45BFloat Cap13.49052wk Low--Dividend TTM105.43MShs Float24.640Historical High--Div YieldTTM2.17%Amplitude0.370Historical Low23.169Avg Price1Lot Size
About Catalyst Pharmaceuticals Company
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Company Profile
SymbolCPRX
Company NameCatalyst Pharmaceuticals
Listing DateNov 8, 2006
Issue Price6.00
Founded2002
CEOMr. Richard J. Daly
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address355 Alhambra Circle,Suite 801
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-305-420-3200
Company Executives
- Name
- Position
- Salary
- Richard J. Daly
- Director, President and Chief Executive Officer
- 14.08M
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 3.40M
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 2.37M
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 2.51M
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 2.15M
- Tamar Thompson
- Independent Director
- 610.43K
- Dr. David S. Tierney,M.D.
- Independent Director
- 370.99K
- Charles B. O'Keeffe
- Lead Independent Director
- 397.24K
- Molly Harper
- Independent Director
- 363.12K
- Donald A. Denkhaus
- Independent Director
- 376.24K
Trending Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.
Unlock Now